These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34852944)

  • 1. Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity.
    Long W; Kunitake S; Sawada SI; Akiyoshi K; Tsubata T
    Vaccine; 2021 Dec; 39(52):7526-7530. PubMed ID: 34852944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle.
    Morimoto N; Hirano S; Takahashi H; Loethen S; Thompson DH; Akiyoshi K
    Biomacromolecules; 2013 Jan; 14(1):56-63. PubMed ID: 23215439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-adjuvanted L-arginine-modified dextran-based nanogels for sustained local antigenic protein delivery to antigen-presenting cells and enhanced cellular and humoral immune responses.
    Chung JT; Rafiei M; Chau Y
    Biomater Sci; 2024 Mar; 12(7):1771-1787. PubMed ID: 38385306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity.
    Muraoka D; Harada N; Hayashi T; Tahara Y; Momose F; Sawada S; Mukai SA; Akiyoshi K; Shiku H
    ACS Nano; 2014 Sep; 8(9):9209-18. PubMed ID: 25180962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.
    Muraoka D; Harada N; Shiku H; Akiyoshi K
    J Control Release; 2022 Jul; 347():175-182. PubMed ID: 35526613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives.
    Zhang T; Yang R; Yang S; Guan J; Zhang D; Ma Y; Liu H
    Drug Deliv; 2018 Nov; 25(1):278-292. PubMed ID: 29334800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.
    Yuki Y; Uchida Y; Sawada SI; Nakahashi-Ouchida R; Sugiura K; Mori H; Yamanoue T; Machita T; Honma A; Kurokawa S; Mukerji R; Briles DE; Akiyoshi K; Kiyono H
    Mol Pharm; 2021 Apr; 18(4):1582-1592. PubMed ID: 33621107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of nanogel-based vaccines.
    Hernández-Adame L; Angulo C; García-Silva I; Palestino G; Rosales-Mendoza S
    Expert Rev Vaccines; 2019 Sep; 18(9):951-968. PubMed ID: 31487213
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Osteoconductive Ability of Two Types of Cholesterol-Bearing Pullulan (CHP) Nanogel-Hydrogels Impregnated with BMP-2 and RANKL-Binding Peptide: Bone Histomorphometric Study in a Murine Calvarial Defect Model.
    Xie C; Rashed F; Sasaki Y; Khan M; Qi J; Kubo Y; Matsumoto Y; Sawada S; Sasaki Y; Ono T; Ikeda T; Akiyoshi K; Aoki K
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural effects and lymphocyte activation properties of self-assembled polysaccharide nanogels for effective antigen delivery.
    Miura R; Tahara Y; Sawada SI; Sasaki Y; Akiyoshi K
    Sci Rep; 2018 Nov; 8(1):16464. PubMed ID: 30405172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.
    Li D; Sun F; Bourajjaj M; Chen Y; Pieters EH; Chen J; van den Dikkenberg JB; Lou B; Camps MG; Ossendorp F; Hennink WE; Vermonden T; van Nostrum CF
    Nanoscale; 2016 Dec; 8(47):19592-19604. PubMed ID: 27748778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
    Kageyama S; Wada H; Muro K; Niwa Y; Ueda S; Miyata H; Takiguchi S; Sugino SH; Miyahara Y; Ikeda H; Imai N; Sato E; Yamada T; Osako M; Ohnishi M; Harada N; Hishida T; Doki Y; Shiku H
    J Transl Med; 2013 Oct; 11():246. PubMed ID: 24093426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza Virus.
    Nagatomo D; Taniai M; Ariyasu H; Taniguchi M; Aga M; Ariyasu T; Ohta T; Fukuda S
    Biomed Res Int; 2015; 2015():471468. PubMed ID: 26421290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.
    Aoki M; Ueda S; Nishikawa H; Kitano S; Hirayama M; Ikeda H; Toyoda H; Tanaka K; Kanai M; Takabayashi A; Imai H; Shiraishi T; Sato E; Wada H; Nakayama E; Takei Y; Katayama N; Shiku H; Kageyama S
    Vaccine; 2009 Nov; 27(49):6854-61. PubMed ID: 19761832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforated Hydrogels Consisting of Cholesterol-Bearing Pullulan (CHP) Nanogels: A Newly Designed Scaffold for Bone Regeneration Induced by RANKL-Binding Peptides and BMP-2.
    Xie C; Satake-Ozawa M; Rashed F; Khan M; Ikeda M; Hayashi S; Sawada S; Sasaki Y; Ikeda T; Mori Y; Akiyoshi K; Aoki K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation.
    Wang C; Li P; Liu L; Pan H; Li H; Cai L; Ma Y
    Biomaterials; 2016 Feb; 79():88-100. PubMed ID: 26702587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen Delivery to Antigen-Presenting Cells for Adaptive Immune Response by Self-Assembled Anionic Polysaccharide Nanogel Vaccines.
    Miura R; Sawada SI; Mukai SA; Sasaki Y; Akiyoshi K
    Biomacromolecules; 2020 Feb; 21(2):621-629. PubMed ID: 31800235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanogel-based delivery system enhances PGE2 effects on bone formation.
    Kato N; Hasegawa U; Morimoto N; Saita Y; Nakashima K; Ezura Y; Kurosawa H; Akiyoshi K; Noda M
    J Cell Biochem; 2007 Aug; 101(5):1063-70. PubMed ID: 17520665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.